OLMA Earnings Date: Nov 9, 2026 (Estimated) — Olema Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is OLMA's next earnings date?
Olema Pharmaceuticals, Inc. (OLMA) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.60 on revenue of $1.3M.
How did OLMA do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Olema Pharmaceuticals, Inc. posted EPS of -$0.61 versus the -$0.55 estimate, a miss of 8.9%. Revenue was $0. The stock's 1-day post-earnings move was -12.6%.
How much does OLMA stock move after earnings?
OLMA beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.1% (up or down) in the day after earnings.
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.55 | -0.61 | -8.93% | $0 | ❌ Miss | -12.65% | -9.80% | -13.23% |
| 2026-05-12 | Q1 2026 | -0.54 | -0.52 | +3.70% | $0 | ✅ Beat | -5.99% | -13.19% | -33.92% |
| 2026-03-16 | Q4 2025 | -0.52 | -0.50 | +3.85% | $0 | ✅ Beat | +12.85% | -4.28% | +10.81% |
| 2025-11-10 | Q3 2025 | -0.44 | -0.49 | -11.36% | $0 | ❌ Miss | +4.19% | +0.60% | +218.32% |
| 2025-08-11 | Q2 2025 | -0.43 | -0.51 | -18.60% | $0 | ❌ Miss | +16.19% | +26.04% | +70.90% |
| 2025-05-13 | Q1 2025 | -0.50 | -0.36 | +28.00% | $0 | ✅ Beat | -3.85% | +8.55% | -13.25% |
| 2025-03-18 | Q4 2024 | 0.17 | -0.51 | -400.00% | $0 | ❌ Miss | -0.72% | +1.21% | +2.90% |
| 2024-11-12 | Q3 2024 | -0.57 | -0.60 | -5.26% | $0 | ❌ Miss | -0.52% | -24.44% | -41.77% |
Showing last 8 quarters.